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Abstract. This study aimed to examine the effect of adherence to clinical outcomes and the 
quality of life of primary hypertension patients in pharmacy. The studywas conducted cross 
sectionally involved 60 patients at one of the pharmacies in Medan, Indonesia. Adherence 
was obtained in the form of adherence levels measured using the MMAS-8 questionnaire, 
clinical outcomes assessed by measuring a patient's blood pressure, and quality of life 
assessed using the EQ-5D-3L questionnaire. Then the data were analyzed using the 
Spearmen rho test. Patients who participated in the study consisted of 24 men and 36 
women. Almost patient has low adherence with blood pressure mean of 156/ 90 mmHg. 
The patient's quality of life was 77.7%. Adherence has a significant relationship to clinical 
outcomes (p<0.05) with a strong correlation of r= -0.745. Adherence has a relationship to 
quality of life (p<0.05) with moderate correlation  r= 0.554. This study concluded that 
adherence has a correlation with clinical outcomes and the quality of life of primary 
hypertension patients. 
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Abstrak. Penelitian ini bertujuan untuk mengkaji pengaruh kepatuhan terhadap outcome 
klinis dan kualitas hidup pasien hipertensi primer di Apotek. Penelitian dilakukan secara 
cross sectional dengan melibatkan 60 pasien di salah satu apotek di kota Medan, 
Indonesia. Data kepatuhan diperoleh dalam bentuk tingkat kepatuhan yang diukur 
menggunakan kuesioner MMAS-8, outcome klinis dinilai dengan mengukur tekanan darah 
pasien, dan data kualitas hidup dinilai menggunakan kuesioner EQ-5D-3L. Kemudian data 
dianalisis menggunakan uji Spearmen rho. Pasien yang mengikuti penelitian terdiri dari 24 
laki-laki dan 36 perempuan. Rata-rata pasien memiliki kepatuhan rendah dengan tekanan 
darah  rata-rata sebesar 156/ 90 mmHg. Kualitas hidup pasien rata-rata diperoleh sebesar 
77,7%. Kepatuhan memiliki hubungan yang signifikan terhadap outcome klinis (p<0,05) 
dengan korelasi kuat r= -0,745. Kepatuhan juga memiliki korelasi terhadap kualitas hidup 
(p<0,05) dengan korelasi cukup r= 0.554).       Penelitian ini menyimpulkan bahwa 
kepatuhan pengobatan mempunyai korelasi dengan outcome klinis dan kualitas hidup 
pasien hipertensi primer.    
Kata Kunci: Adherence, Hypertension, Pharmacy, Quality of life. 
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1. Introduction 
Data from WHO in 2017 showed that there were 17.9 million people in the world who died 
from cardiovascular disease or about 31% of the total deaths worldwide [1]. Hypertension is one 
of the risk factors for cardiovascular disease. In 2015, an increase in blood pressure resulted in 
9.4 million deaths and was a disease that increased Disability-Adjusted Life Years [2]. WHO 
data for 2019 estimated that at least 1.13 billion people in the world suffer from hypertension.  
The treatment of hypertension in Asian countries is very important because the prevalence of 
hypertension continuesly to increase, including in Indonesia [3]. Indonesia Basic Health 
Research in 2018 reported that the number of hypertension patients increased from 25.8% in 
2013 to 34.1% in 2018 based on blood pressure measurements in the age group 18 and older [4]. 
High quality medicines are already widely prescribed for patients, but there are more than 50% 
of non-adherence patients. In asimptomatic diseases such as hypertension, the non-adherence 
can reach 80% [15]. Low levels of patient adherence to treatment of hypertension are the main 
problems of complications, decreased effectiveness of treatment, and resulting in increased 
mortality [6], [8]. Non-adherence lead to uncontrolled blood pressure.  In United States, only 
50% of patients had controlled their blood pressure. Non-adherence patients are more likely to 
experience of cardiovascular complications indeed death compared with the adherence patients 
[9]. Some factors affected non-adherence were reported by several studies, including age, 
presence or absence of comorbid diseases, number of medicines taken, and patients knowledge 
[10], [11], [12]. The patient quality of life is also influenced by factors related to physical, 
emotional, social conditions as well as factors related to medication treatment [13]. 
Hypertension also related to quality of life.  Patients with hypertension tend to have a poor 
quality of life compared to patients with normal blood pressure [14], [15]. The poor quality of 
life due to they  have the risk of complications and adverse effects form medicines. The main 
factor affected the quality of life of hypertensive patients are mental and emotional conditions  
[14].  
There are several studies related to adherence and the quality of life of hypertensive patients, but 
very limited data is obtained from pharmacies. This study aimed to examine the effect of 
adherence to clinical outcomes and the quality of life of primary hypertension patients in 
pharmacy. 
2. Material and Methods 
2.1 Patients and study design 
This was an observational study through cross sectional design in one of pharmacies in Medan, 
North Sumatera, Indonesia on July-Augustus 2020. The study was conducted on hypertensive 
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patients who were redeemed the medical prescription at the pharmacy and meet the inclusion 
criteria (patient diagnosed with primary hypertension more than 2 months, aged older than 18 
years, and signed the inform consent.  This study has been approved by the Ethical Committee 
of the Health Research, Faculty of Nursing, Universitas Sumatera Utara No. 2175/VII/SP/2020.  
2.2 Measurement of adherence by MMAS-8, clinical outcome, and quality of life 
Adherence was measured by the 8-item Morisky Medication Adherence Scale (MMAS-8) 
questionnaire. The study used MMAS-8 version of Indonesia contained 8 questions with closed 
dichotomous (yes/no) answer. The questionnaire has been validated with high reliability and 
validity well [16].  Respons of the questions were scored from 0 to 8 for adherence. Total score 
were translated into 3 category, they were high adherence (score 8), medium adherence (score 6 
to <8), and low adherence (score <6).  
Clinical outcome was assed by blood pressure measure using digital blood pressure device. The 
outcome was recorded as systol and diastol. The number was used to interpret clinical outcome 
to adherence scale.  
Quality of life was measured by EQ-5D-3L consist of 5 dimensions (mobility, self-care, usual 
activities, pain/ discomfort, and anxiety/ depression), and has 3 levels (no problems, some 
problems, and extreme problems) of each dimension. Health state was converted to utility score. 
EQ-5D index score was measured using UK value set [17]. Utility range of EQ-5D from 0.0 (the 
worst health) to 1.0 (the best health).  
2.3 Data analysis 
The correlated data were adherence versus clinical outcome and adherence versus quality of life. 
The value of systolic and diastolic blood pressure were obtained by the mean of  blood pressure 
measurements. EQ-5D-3L assessment was performed by precentage of quality of life. 
Furthermore, data analysis was displayed using SPSS version of 22 by Spearmen rho test. 
3. Result and Discussion 
Patients who participated in the study consisted of 24 men and 36 women. Characteristic of 
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Table 1. Patient Characteristics 
Characteristic 
Total 
n (60) Perscentage 
(%) 
gender 
Man 24 40 
Women 36 60 
Age (years) 
36-45 6 10 
46-55 17 28 
56-65 25 42 
>65 12 20 
Level of education 
junior high school 2 3 
senior high school 28 47 
bachelor  30 50 
Occupation  
Unemployed 1 2 
Entrepreneur 20 33 
Housewife 15 25 
Officer 14 23 
Pensionary 10 17 
By the age, 42% patients were 56-65 years old and half of respondents graduated from 
universities. Overall women had higher admissions (60%) compare to those man (40%). By the 
gender, the result in accordance with Peltzer and Pengpid (2018), 31.0% experienced by men 
and 33.4% in women [18]. Otherwise, Everett and Zajacova (2015) found that women was less 
likely affected of hypertensive (12%) compared those to men (27%) [19].  There are many 
factors affected hypertension prevalence, as psychological, life styles, social support, economic 
factor and others are also relevant to change the hyepertension state [20]. 
With regard to adherence, almost patients had a low adherence (52.6%) with blood pressure 
mean of 156/90 mmHg. Only 22.8% of patients were highly adherence. Table 2 displyed the 
correlation of adherence with clinical outcomes.  










Sig. (2-tailed) . .000 





Sig. (2-tailed) .000 . 
N 60 60 
**. Correlation is significant at the 0.01 level (2-tailed). 
Based on statistical analysis, adherence has a significant relationship to clinical outcomes 
(p<0.05) with a strong correlation of r= -0.745. The correlation coefficient was negative referred 
to adherence and clinical outcomes has an inverse correlation, in case adherence decreases, 
blood pressure become increase that indicated the decrease in clinical outcomes. There are many 
factors affected the adherence of patients to take medication. According to Mekonnen et al. 
(2017) study, patients who had experienced three or more years on taking antihypertensive 
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medication had two times more likely adhere compared to those patients with less than three 
years. In developing countries, patients with high adherence were the most important challenge 
to maintan their adherence understanding [21]. Mouraet al. (2016) reported that personal 
reasons become the highest factors (70.3%) contributed to non-adherence, while non-
pharmacological dan pharmacological treatment contributed at 15.9% nd 21%, respectively 
[22]. The global burden of hypertension described systolic blood pressure ≥140 mmHg and 
diastolic blood pressure ≥90 mmHg or antihypertensive treatment was estimated to increase 
from 918 million in year 2000 to 1.56 billion in 2025 [23]. Based on Table 3, patient's quality of 
life was 77.7%.  












Sig. (2-tailed) . .000 





Sig. (2-tailed) .000 . 
N 60 60 
**. Correlation is significant at the 0.01 level (2-tailed). 
Only 1.8%of the anxiety or depression was the extremely problems for quality of life 
dimension. Adherence has a relationship to quality of life (p<0.05) with moderate correlation  
r= 0.554. Correlation coefficien was positive, showed that the higher of adherence, the better of 
quality of life. The result also supported by previous study, a positive correlation was detected 
in adherence and quality of life, however the study has a strong correlation [24]. This was 
probably due to the differences of hypertension stage observed. The study at Cumhuriyet 
University Hospital revealed the positive correlation of adherence and quality of life on physical 
and mental health which  mental health score was higher than the physical score [24]. 
Otherwise, Souza et al (2016) in a systematic review of hypertensive patients revealed the 
physical score health was higher than mental score [25]. A cross-sectional study in Alwatani 
Hospital-Palestine revealed the high adherence (evaluated by MMAS) showed the higher 
quality of life score  (evaluated by the EQ-5D) [26]. The poor quality of life was associated with 
low adherence for numerous reasons including psychosocial well-being and the attitude of 
hypertensive patients toward taking medications [27]. Overall, adherence as a promoting factor 
for quality of life in pharmacological treatment provided the awareness of hypertensive patients 
to chase the health behaviour [25].  
 For further research, needed to emphasize the patients adherence for improving clinical 
outcomes and quality of life. 
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4. Conclusion 
This study concluded that adherence has a correlation with clinical outcomes and the quality of 
life of primary hypertension patients. 
Acknowledgement 
The authors are grateful thank to Faculty of Pharmacy, Universitas Sumatera Utara for the 
facilities support. 
REFERENCES 
[1] Ministry of health of Indonesia. Indonesia health profile 2016. Jakarta: Data and 
Information Center of the Health Ministry of Republic of Indonesia, 2017. 102p. 
[2] WHO. Global Status Report on Noncommunicable Diseases. Switzerland: WHO, 2014. xiv 
p. 
[3] PERKI. Guidelines for management of dyslipidemia. Jakarta: Centra Communications, 
2017. 10-14 p. 
[4] Ministry of health of Indonesia. Health Research 2018, Jakarta: Health Ministry of 
Republic of Indonesia, 2018. 156-160 p. 
[5] M.T. Brown, J. Brussell, S. Dutta, K. Davis, S. Strong, S. Mathew. “Medication 
Adherence: Truth and Consequences,” The American Journal of the Medical Sciences, vol. 
351, no. 4, pp. 387-399. 2016. 
[6] A.P.F. Maciel, H.B. Pimenta, A.P. Caldeira. “Quality of life and medication adherence 
in hypertensive patients,” Acta Paul Enferm, vol. 29, no. 5, pp. 542-548. 2016. 
[7]  C.D. Barbosa, M.M. Balp, K. Kulich, N. Germain, D. Rofail. “A Literature Review to 
Explore the Link between Treatment Satisfaction and Adherence, Complience, and 
Persistence.” Patient Preference and Adherence, vol. 6, pp. 39-48. 2012. 
[8]  G.U. Iloh, A.N. Amadi. “Treatment Satisfaction, Medication Adherence, and Blood 
Pressure Control among Adult Nigerians with Essential Hypertension,” International 
Journal of Health & Allied Sciences, vol. 6, no. 2, pp. 75-81. 2017. 
[9] H. G.S. Femida, E. Manias, L. Lal, M. Salas, D.A. Hughes, A. R. Leewing, M. Grubisic. 
“Impact of Interventions on Medication Adherence and Blood Pressure Control in 
Patients with Essential Hypertension: A Systematic Review by the ISPOR Medication 
Adherence and Persistence Special Interest Group,” Value Health, vol. 16, no. 5, pp. 
863-871. 2013. 
[10] O. Amaral, C. Chaves, J. Duarte, E. Countinho, P. Nelas, O. Preto. “Treatment 
Adherence in Hypertensive Patients-A Cross-sectional Study,” Sociall and Behavioral 
Sciences, vol. 171, pp. 1288-1295. 2014. 
[11] M. Burnier. “Drug Adherence in Hypertension,” Pharmacological Research., vol. 125, 
pp. 142-149. 2017. 
[12] S. Boratas, H.F. Kilic. “Evaluation of Medication Adherence in Hypertensive Patients 
and Influential Factors,” Pakistan Journal of Medical Sciences. Vol. 34, no. 4, pp. 1-5. 
2018. 
[13] B. Uchmanowicz, A. Chudiak, G. Mazur. “The influence of quallity of life on the level 
of adherence to therapeutic recommendations among elderly hypertensive patients”, 
Patient Preference and Adherence, vol. 12, pp. 2593-2603. 2018. 
[14] M. Amer, N. U. Rahman, S.U.R. Nazir, A. Raza, H. Riaz, M. Sultana, S. Sadeeqa. 
“Impact of Pharmacist’s Intervention on Disease Related Knowledge, Medication 
Adherence, HRQoL and Control of Blood Pressure Among Hypertensive Patients,” Pak. 
J. Pharm. Sci, vol. 31, no. 6, pp. 2607-2616. 2018. 
[15] Q. Yao, C.  Liu, Y. Zhang, L, Xu. “Health-Related Quality of Life of People with Self-
Reported Hypertension: A National Cross-Sectional Survey in China,” International 
Journal of Environment Research and Public Health, vol. 16, no. 72, pp. 1-24. 2019. 
[16] D.A. Riani, Z. Ikawati, S.A. Kristina. “Validasi 8-item Morisky Medication Adherence 
53 
  
Indonesian Journal of Pharmaceutical and Clinical Research (IDJPCR) Vol. 03, No. 2, 2020 
Scale versi Indonesia pada pasien hipertensi dewasa di puskesmas kabupaten Sleman 
dan kota Yogyakarta,” Tesis,  Universitas Gadjah Mada, 2017. 
[17] EuroQol Research Foundation. EQ-5D-3L User Guide. Basic Information on How to 
Use the EQ-5D-3L Instrument.  Netherlands: Euroqol. 2018; 7-14 p. 
[18] K. Peltzer, S. Pengpid. “The prevalence and social determinants of hypertension among 
adults in Indonesia: a cross-sectional population-based national survey,” International 
Journal of Hypertension, pp.1-9. 2018.  
[19] B. Everett, A. Zajacova. “Gender differences in hypertension and hypertension 
awareness among young adult,” Biodemography Soc. Biol, vol. 61, no. 1, pp. 1-17. 2015. 
[20] S.S.B.E. Silva, S.F.S.B. Oliveira, A.M.G. Pierin. “The control of hypertension in men 
and women: a comparative analysis,” Journal of School of Nursing USP, vol. 5, no.  1, 
pp.50-58. 2016. 
[21] H.S. Mekonnen, M.H.  Gebrie, K.H. Eyasu, A.A. Gelagay. “Drug adherence for 
antihypertensive medications and its determinants among adult hypertensive patients 
attending in chronic clinics of referral hospitals in Northwest Ethiopia,” BMC 
Pharmacology and Toxicology, vol. 18, no. 27,  pp. 1-10. 2017. 
[22] A.A. Moura, S. Godoy, C.B. Cesarino, I.A.C. Mendes. “Factor determinig non-
adherence to hypertension treatment,”  Enfermerfe Global, pp. 27-39. 2016. 
[23] M. Burnier, B.M. Egan. “Adherence in Hypertension, A Review of Prevalence, Risk 
Factors, Impact, and Management,” AHAjournal, pp.1124-1140. 2019. 
[24] M. Mollaoglu, G. Solmaz, M. Mollaoglu. “Adherence to therapy and quality of life in 
hypertensive patients,” Acta Clin Croat, vol. 54, pp.438-444. 2015. 
[25] A.C.C. Souza, J.W.P. Borges, T.M.M. Moreira. “Quality of Life and Treatment 
Adherence in Hyertensive Patientss: systematic review with meta-analysisis,”Revista de 
Saude Publica, vol. 50, no. 71, p. pp. 1-14. 2016. 
[26] S.H. Zyoud, W. Al-Jabi, W.M. Sweileh, A.H. Wildali, H.M. Saleem, H.A. Aysa, M.A. 
Badwan, R. Awang, D.E. Morisky. “Health-related Quality of Life Associated with 
Treatment Adherence in Patients with Hypertension: A Cross-Sectional Study,” 
International Journal of Cardiology, vol. 168, no. 3, pp. 2981-2983. 2013. 
[27] E.W. Holt, P. Muntner, C.J. Joyce, L. Webber, M.A.K. Wood. “Health-related Quality 
of Life and Antihypertensive Medication Adherence among Older Adults,” Age and 
Ageing, vol. 39, pp. 481-487. 2010. 
 
 
 
